Indeed, our biochemical and genomic studies elucidated a mechanism in which nuclear CHMP5 amplified p300 interaction with BRD4 and consequently, improved both p300 and BRD4 binding selectively at enhancer and super-enhancer elements at key T-ALL genes (Figure S4C). This evidence concerns the gene EP300 and acute lymphoblastic leukemia.